Jun 16, 2026 08:33AM
Jun 16, 2026 08:30AM
Jun 9, 2026 08:01AM
Jun 9, 2026 08:00AM
May 14, 2026 04:15PM
May 14, 2026 04:15PM
Apr 20, 2026 05:00PM Alpha Cognition appoints Bethany Sensenig to board of directors
Apr 20, 2026 05:00PM
Mar 26, 2026 04:01PM
Mar 26, 2026 04:01PM
Mar 10, 2026 08:30AM
Feb 18, 2026 08:30AM
Feb 18, 2026 08:30AM
Dec 1, 2025 05:51PM Alpha Cognition to Participate in Virtual Fireside Chat Hosted by Titan Partners
Nov 13, 2025 04:00PM
Oct 14, 2025 04:30PM
Oct 6, 2025 08:30AM
Aug 14, 2025 08:30AM
Jul 29, 2025 08:32AM
Jul 29, 2025 08:30AM
Jul 8, 2025 08:30AM Alpha Cognition to Present ZUNVEYL® (Benzgalantamine) Study Data at Alzheimer’s Association International Conference
Jul 1, 2025 05:05PM
Jul 1, 2025 05:05PM
May 15, 2025 08:30AM
Apr 30, 2025 07:30AM
Apr 28, 2025 08:30AM
Apr 10, 2025 08:30AM
Mar 18, 2025 08:30AM Alpha Cognition Announces the Commercial Launch of ZUNVEYL (Benzgalantamine) for the Treatment of Mild to Moderate Alzheimer’s Disease
Jan 8, 2025 08:32AM
Jan 8, 2025 08:30AM
Jan 6, 2025 08:30AM
Nov 15, 2024 05:00PM
Nov 12, 2024 09:22AM
Oct 15, 2024 08:30AM
Sep 24, 2024 05:16PM Alpha Cognition Announces Completion of $4.545 Million (USD) Convertible Note and Warrants Bridge Financing
Aug 19, 2024 08:30AM
Aug 12, 2024 04:35PM
Jul 29, 2024 08:08AM
May 14, 2024 07:24PM
Apr 3, 2024 10:08PM
Mar 1, 2024 07:53AM
Feb 22, 2024 08:30AM Alpha Cognition Files U.S. Patent Application Covering an ALPHA-1062 Oral Formulation to Treat Mild to Moderate Alzheimer’s Disease
Feb 12, 2024 08:30AM
Dec 7, 2023 04:35PM
Nov 28, 2023 04:45PM
Sep 27, 2023 04:30PM
Aug 22, 2023 04:05PM
May 30, 2023 12:15PM
Mar 8, 2023 06:24PM Alpha Cognition Announces Fourth Quarter and Full Year 2022 Results and Provides Corporate Update
Jan 19, 2023 03:00PM

323,573 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All